BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12827974)

  • 1. Myelin molecules limiting nervous system plasticity.
    Schnaar RL
    Prog Mol Subcell Biol; 2003; 32():125-42. PubMed ID: 12827974
    [No Abstract]   [Full Text] [Related]  

  • 2. [Regeneration and plasticity of the injured central nervous system].
    Yamashita T; Hata K; Yamaguchi A; Kubo T
    Tanpakushitsu Kakusan Koso; 2007 Jan; 52(1):11-7. PubMed ID: 17228835
    [No Abstract]   [Full Text] [Related]  

  • 3. Where no synapses go: gatekeepers of circuit remodeling and synaptic strength.
    Mironova YA; Giger RJ
    Trends Neurosci; 2013 Jun; 36(6):363-73. PubMed ID: 23642707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroscience. It takes more than two to Nogo.
    Woolf CJ; Bloechlinger S
    Science; 2002 Aug; 297(5584):1132-4. PubMed ID: 12183616
    [No Abstract]   [Full Text] [Related]  

  • 5. Myelin-associated inhibitors of axon regeneration.
    Grados-Munro EM; Fournier AE
    J Neurosci Res; 2003 Nov; 74(4):479-85. PubMed ID: 14598291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
    McGee AW; Strittmatter SM
    Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular approaches to spinal cord repair.
    David S; Lacroix S
    Annu Rev Neurosci; 2003; 26():411-40. PubMed ID: 12626698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Axon growth inhibition signals and strategies to treat injuries to the central nervous system].
    Yamashita T
    Tanpakushitsu Kakusan Koso; 2008 Mar; 53(4 Suppl):406-10. PubMed ID: 21089311
    [No Abstract]   [Full Text] [Related]  

  • 9. Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA.
    Schweigreiter R; Walmsley AR; Niederöst B; Zimmermann DR; Oertle T; Casademunt E; Frentzel S; Dechant G; Mir A; Bandtlow CE
    Mol Cell Neurosci; 2004 Oct; 27(2):163-74. PubMed ID: 15485772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanism and regulation of axon growth inhibition].
    Yamashita T
    Brain Nerve; 2007 Dec; 59(12):1347-53. PubMed ID: 18095484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nogo: a molecular determinant of axonal growth and regeneration.
    Grandpré T; Strittmatter SM
    Neuroscientist; 2001 Oct; 7(5):377-86. PubMed ID: 11597097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor.
    McGee AW; Yang Y; Fischer QS; Daw NW; Strittmatter SM
    Science; 2005 Sep; 309(5744):2222-6. PubMed ID: 16195464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
    Saha N; Kolev M; Nikolov DB
    Neurosci Res; 2014 Oct; 87():1-7. PubMed ID: 24956133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors for myelin inhibitors: Structures and therapeutic opportunities.
    Cao Z; Gao Y; Deng K; Williams G; Doherty P; Walsh FS
    Mol Cell Neurosci; 2010 Jan; 43(1):1-14. PubMed ID: 19619659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nogo and the Nogo-66 receptor.
    Fournier AE; GrandPré T; Gould G; Wang X; Strittmatter SM
    Prog Brain Res; 2002; 137():361-9. PubMed ID: 12440378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration.
    Sivasankaran R; Pei J; Wang KC; Zhang YP; Shields CB; Xu XM; He Z
    Nat Neurosci; 2004 Mar; 7(3):261-8. PubMed ID: 14770187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming inhibition in the damaged spinal cord.
    Fawcett JW
    J Neurotrauma; 2006; 23(3-4):371-83. PubMed ID: 16629623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory proteins against axon regeneration in the central nervous system].
    Hu JG; Lu PH; Xu XM
    Sheng Li Ke Xue Jin Zhan; 2004 Oct; 35(4):311-4. PubMed ID: 15727207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury.
    Simonen M; Pedersen V; Weinmann O; Schnell L; Buss A; Ledermann B; Christ F; Sansig G; van der Putten H; Schwab ME
    Neuron; 2003 Apr; 38(2):201-11. PubMed ID: 12718855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.